Remote temperature monitoring device
Device- Use of the Tucky® remote monitoring device for continuous temperature monitoring at home,
- In combination with education sessions on temperature monitoring and the device.
NCT Number: NCT06697262
The goal of this clinical trial is to evaluate the feasibility of the study, measured by the acceptability rate of patients to be recruited in a study proposing temperature monitoring at home, by a remote monitoring device or by the visit of an IDE at home (in association with the usual educational sessions), to children at risk of febrile neutropenia, from families with psycho-social vulnerabilities.
The main questions it aims to answer are:
* Will participants adhere to the telemonitoring system? * Is the intervention feasible, in terms of the device's failure to record temperature data? * Will parents behave appropriately when using the device? * How satisfied will parents and caregivers be? * What will be the physical tolerance of the device? * On an exploratory basis, will the remote monitoring system be effective for months?
Researchers will compare :
* patients using the telemonitoring device for continuous temperature monitoring at home, in combination with education sessions on temperature monitoring and the device * with patient with temperature monitoring at home by a nurse, 2 times a day, in combination with education sessions on temperature monitoring (without the telemonitoring device at home)
Trial opening soon.
Get Notified0 year–17 year
All sexes
Interventional
Not applicable
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
patient
Exclusion criteria
Patient:
Time frame: 24 months
number of patients included/number of eligible patients offered the study.
Contact information is provided by the study sponsor or research team.
Centre Hospitalier Universitaire de la Réunion
Other
Impact of a Telemonitoring Device on the Occurrence of Fever at Home in Children at Risk of Chemotherapy-Induced Neutropenia: A Pilot Randomized Controlled Trial
Acronym: TELEDOM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06500715
Agranulocytosis, Cross Infection
Jerusalem, Israel
View Trial DetailsNCT06988826
Agranulocytosis, Antibiotic Therapy
View Trial DetailsNCT06450821
Agranulocytosis, Cytopenia
Leeds, West Yorkshire, United Kingdom
View Trial DetailsNCT06278896
Agranulocytosis, Antibiotic Stewardship
View Trial Details